Revealing the Patient Perspective: Evolution of Patient‐Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine

20251 citationsReviewhybrid Open Access

Authors

Steven Dayan · Denova Research

Alexander Rivkin · University of California, Los Angeles

Patricia Ogilvie

Jean Carruthers · University of British Columbia

Yan Wu · Peking University

Elisabeth Lee · AbbVie (United States)

Vaishali Patel · AbbVie (United States)

Abstract

A patient-centric approach, in lockstep with regulatory requirements, has been central to onabotulinumtoxinA development. Awareness of the comprehensive benefits of aesthetic treatments should continue to improve based on increasingly robust PROs.

Topics & Keywords

Botulinum Toxin and Related Neurological Disorders Sympathectomy and Hyperhidrosis Treatments Facial Rejuvenation and Surgery Techniques

Publication Details

Published in: Journal of Cosmetic Dermatology

Volume 24, Issue 7, pp. e70311-e70311

DOI: 10.1111/jocd.70311

Field-Weighted Citation Impact: 1.45

Command Palette

Revealing the Patient Perspective: Evolution of Patient‐Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine

Authors

Abstract

Topics & Keywords

Publication Details